FAQ
- If you had to sum up the strength of Helene Clinic in just one word, what would it be?
With a track record of 17,000 cases and a cell quality of 2.25 billion cells per treatment thanks to proprietary technology, we are a leading stem cell therapy company operating in four locations worldwide.
17,000+ clinical cases and 2.25 billion cells per dose via proprietary technology. The global leader in stem cell therapy with 4 international hubs.
- What are the advantages of choosing Helene Clinic over other stem cell clinics?
The biggest difference lies in the sheer volume of our experience and the concentration of cells we can provide. Our vast knowledge gained from a total of 17,000 cases allows us to propose the optimal administration plan tailored to each individual case. Furthermore, our global operations across four locations mean we can quickly incorporate the latest world-class technologies into our treatments—a strength unmatched by other hospitals.
- Does Helene clinic collaborate with any research institutions or universities, either in Japan or internationally?
Yes. Our clinic has earned technical recognition from world-renowned leaders in stem cell research, including prominent professors from the University of Cambridge. Additionally, our internal research division analyzes clinical data on a daily basis, sharing our advanced insights with the world through international academic conferences and official press releases. This powerful, global research network serves as the very foundation of our position as an industry leader.
- How does your international presence and overseas expansion directly benefit patients?
By establishing our presence across the globe, we are able to seamlessly integrate not only Japanese standards but also the stringent medical regulations and cutting-edge research insights from Europe and the Middle East. Furthermore, our international hubs enable us to collaborate directly with renowned university hospitals and elite research institutions worldwide, and this global foundation of trust is precisely why we are recognized as a leading name in stem cell therapy.
- Does Helene Clinic have international locations outside of Japan?
Yes, Helene Group is headquartered in Tokyo, Japan, and boasts a powerful global footprint across four premier international hubs: London (UK), Dubai (UAE), and Abu Dhabi (UAE). By seamlessly exchanging the latest regulatory updates and scientific breakthroughs from each region, we continuously advance a world-leading network in regenerative medicine.
- What is the global demographic of the patients who visit your clinic for treatment?
Our patients not only from here in Japan, but from all over the globe, including China, Vietnam, Hong Kong, Singapore, Indonesia, the Middle East, Europe, and the Americas. > In particular, affluent individuals and highly health-conscious clients choose us because they deeply value our overwhelming clinical track record and rigorous safety standards, allowing us to continuously serve as a premier hub for global medical tourism.
- What is your clinic’s total number (proven track record) of cases in stem cell therapy?
Since its opening in 2013, our hospital has been a pioneer in regenerative medicine in Japan. Our group has treated over 17,000 cases in total (as of the end of 2026), a record that is among the top in Japan and globally. Based on our many years of clinical experience, we provide personalized medicine tailored to each individual patient.
- Is your hospital a medical institution in Japan?
Our clinic is a specialized regenerative medicine clinic in Japan, and all medical procedures are performed by medical professionals holding Japanese medical and nursing licenses. Dr. Matsuoka, the clinic director, is committed to spreading regenerative medicine globally and has established a multilingual support system to ensure that more patients can receive medical care with peace of mind. We provide high-quality medical services to patients from all over the world, regardless of nationality.
